You are here

Atacand

AstraZeneca sells US rights to 4 non-core drugs

AstraZeneca sells US rights to 4 non-core drugs

Biopharma Dive

ANI Pharmaceuticals

Flag link:

FDA takes a closer look at possible cancer risks of widely used blood pressure medicines

FDA takes a closer look at possible cancer risks of widely used blood pressure medicines

Star Ledger, NJ

Bristol-Myers Squibb

Flag link:

AstraZeneca to pay Merck $647M for drug interests

AstraZeneca to pay Merck $647M for drug interests

Yahoo/AP

Flag link: